Chuchu Shao

300 Guangzhou Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

BIRC5 expression correlates with immunosuppressive phenotype and predicts inferior response to immunotherapy in lung adenocarcinoma.

BIRC5 expression correlates with immunosuppressive phenotype and predicts inferior response to immunotherapy in lung adenocarcinoma.

Journal: Journal of thoracic disease

Published: February 03, 2025

Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease.

Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease.

Journal: Thoracic cancer

Published: December 31, 2023

Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer.

Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer.

Journal: Cancer cell

Published: November 18, 2023

Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation.

Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation.

Journal: Chinese medical journal

Published: March 15, 2023

Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusion.

Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusion.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 10, 2023

High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterations.

High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterations.

Journal: Translational lung cancer research

Published: April 23, 2021

Case Report: Abscopal Effect of Microwave Ablation in a Patient With Advanced Squamous NSCLC and Resistance to Immunotherapy.

Case Report: Abscopal Effect of Microwave Ablation in a Patient With Advanced Squamous NSCLC and Resistance to Immunotherapy.

Journal: Frontiers in immunology

Published: April 17, 2021

Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung Cancer.

Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung Cancer.

Journal: Cancer management and research

Published: January 21, 2021

ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLC.

ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLC.

Journal: Cancer immunology, immunotherapy : CII

Published: September 15, 2020

Role of hypoxia in cancer therapy by regulating the tumor microenvironment.

Role of hypoxia in cancer therapy by regulating the tumor microenvironment.

Journal: Molecular cancer

Published: May 31, 2019

The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis.

The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis.

Journal: BMC cancer

Published: May 16, 2019

4-Hydroxy estrogen metabolite, causing genomic instability by attenuating the function of spindle-assembly checkpoint, can serve as a biomarker for breast cancer.

4-Hydroxy estrogen metabolite, causing genomic instability by attenuating the function of spindle-assembly checkpoint, can serve as a biomarker for breast cancer.

Journal: American journal of translational research

Published: May 08, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026